Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Tempest Therapeutics, Inc. (TPST) had Free Cash Flow of $-26.82M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-4.02M |
|
-- |
|
-- |
|
$4.08M |
|
$-4.08M |
|
$0.06M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.08M |
|
$-4.01M |
|
4.15M |
|
4.15M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$8.27M |
|
$0.60M |
|
$8.66M |
|
$16.93M |
|
$3.31M |
|
-- |
|
$6.95M |
|
$10.26M |
|
$6.67M |
|
$6.67M |
|
$6.67M |
|
4.93M |
|
| Cash Flow Statement Financials | |
$-26.82M |
|
-- |
|
$4.26M |
|
$30.71M |
|
$8.15M |
|
$-22.56M |
|
$3.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-26.82M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-60.30% |
|
-60.30% |
|
-23.75% |
|
-60.30% |
|
$1.35 |
|
$-6.46 |
|
$-6.46 |
|